The article examines the importance of T cell immunity in the effectiveness of current COVID-19 vaccines. The central question of the paper focuses on how T cell responses contribute to protection against SARS-CoV-2, especially when antibody responses decline or become less effective against new variants. While antibodies have received the most attention during the pandemic, this paper argues that T cells are equally important for maintaining long term immunity and reducing severe disease outcomes.

The article explains that most COVID-19 vaccines were designed to target the spike protein of SARS-CoV-2. The vaccines successfully generate neutralizing antibodies, which block the virus from entering host cells. However, one challenge discussed in the paper is that antibody levels decrease over time. In addition, variants such as Omicron have developed mutations in the spike protein, allowing them to partially escape antibody recognition. This means vaccinated individuals may still experience infections, even after receiving booster doses. The article raises the question of whether vaccine protection remains strong despite these changes

The paper highlights that T cells provide a second layer of defense. Unlike antibodies, T cells do not prevent infections directly. Instead, they recognize infected cells and destroy them, limiting viral spread throughout the body. The article describes two major types of T cells involved in this process. CD4+ helper T cells coordinate immune responses by supporting B cells and helping activate CD8+ T cells. CD8+ cytotoxic T cells directly kill infected cells. Together, their responses reduce disease severity and improve viral clearance.

One of the most important findings discussed in the article is that T cell responses are much less affected by viral mutations than antibodies. This is because T cells recognize multiple peptide fragments, called epitopes, from different parts of the virus. Even when mutations occur in the spike protein, many of these epitopes remain unchanged. The paper explains that studies have shown most T cell responses remain preserved across variants. This finding is important because it helps explain when vaccinated individuals continue to have strong protection against hospitalization and death, even if breakthrough infections happen

The article also discusses immune memory and durability. T cell memory appears to last longer than antibody responses, which means protection against severe disease may remain even after antibody level decline. This long term memory allows the immune system to respond faster upon re-exposure to the virus. The article emphasizes that this durability is a major strength of the current vaccines and an
important reason why booster doses can restore and strengthen immunity. This article relates strongly to course material because it demonstrates the importance of adaptive immunity, specifically cellular immunity. In immunology, we learn that B cells and antibodies are only part of protection. T cells play an equally critical role, especially against viruses that infect host cells. The article reinforces the idea that immunity is not only about preventing infection but also about controlling disease progression. This helps explain why COVID-19 vaccines remain highly valuable even when new variants emerge

In conclusion, the article shows that T cell immunity is a key factor in the success of current COVID-19 vaccines. Although antibodies may decrease over time and lose effectiveness against new variants, T cells remain more stable and continue to provide protection against severe disease. The paper emphasizes that understanding T cell responses is essential for improving future vaccine strategies and for maintaining long- term control of COVID-19. Overall, this article expands our understanding of how vaccines work and highlights the critical role of T cells in protective immunity

References
Moss P. T cells in current COVID-19 vaccines. Science. 2022;377(6608):803-804.
doi:10.1126/science.add2897.